Howard Capital Management Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1733173
ROSWELL, GA
Position in REGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,918,632
+$883,295 QoQ
Shares Held
3,077
+129.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#521
of 1,322 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Howard Capital Management Inc. holds $7,085,291 across 3 Biotechnology names. REGN ranks #2 (27.1% of the industry book) .
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,918,632 | 3,077 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,035,337 | 1,340 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,398,971 | 3,108 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,709,300 | 3,040 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,610,175 | 3,067 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,718,129 | 2,709 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,209,647 | 3,102 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $3,167,386 | 3,013 | Shares | Sole | 2024-11-12 | |
| 2020-09-30 | $204,879 | 366 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $211,417 | 339 | Shares | Sole | 2020-07-13 | |
| No filing history on record for this holder in this stock. | ||||||